Brainsway (BWAY) Other financing activities (2019 - 2024)
Brainsway (BWAY) posted quarterly Other financing activities of $3.4 million for Q4 2024, up 171350.0% on a QoQ basis from -$2000.0 in Q3 2020.
Brainsway (BWAY) Other financing activities (2019 - 2024) Analysis & Trends
Brainsway (BWAY) has reported Other financing activities for 3 consecutive years, with $3.4 million the latest figure, recorded in Q4 2024.
- Quarterly Other financing activities changed N/A year-over-year to $3.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.4 million (changed N/A YoY) and the FY2024 annual result came in at $3.4 million, changed N/A from the prior year.
- Other financing activities improved to $3.4 million in Q4 2024 per BWAY's latest filing, from -$2000.0 in the prior quarter.
- Over the last five years, Other financing activities for BWAY reached as high as $3.4 million in Q4 2024 and fell as low as -$3000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.43 Mn |
| Dec 31, 2024 | 3.43 Mn |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | -3,000.00 |
| Jun 30, 2020 | -3,000.00 |
| Jun 30, 2019 | 1.01 Mn |
| Jun 30, 2019 | 1.01 Mn |